HEOR and market access services
An integrated, end-to-end HEOR offer built around one evidence strategy, from early development to post-launch.
Literature reviews
HTA and EU JCA compliant systematic, targeted, scoping, umbrella, rapid and living reviews.
Scientific communications
Protocols, reports, abstracts, posters, manuscripts, dossiers, global value dossiers and value stories.
Evidence synthesis and analytics
Meta-analysis, NMA, MAIC, STC, survival analyses, utility mapping, and clinical trial and PRO analysis.
Economic modelling
Early and submission-ready models: CEA, CUA, CMA and BIM, built de novo or adapted country by country.
HTA and EU JCA submissions
Dossiers, PICO scoping and EU Joint Clinical Assessment readiness.
Real-world evidence
Claims, electronic health record, registry and chart review studies.
Digital and innovative solutions
AI tools, web-based models, dashboards, slide decks and graphical abstracts.
Patients should not be left waiting for treatments that can change their lives.
We are committed to a healthcare system where value is measured fairly and decisions are guided by sound evidence. Tell us what you are working on and we will show you how we would approach it.
